doc. MUDr. Michal Staník, Ph.D.
Department vice-head, Department of Surgical Oncology
Total number of publications: 44
2022
-
Oncological outcomes of surgery for isolated retroperitoneal recurrence in renal cancer patients after radical nephrectomy
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, year: 2022, volume: 40, edition: 3, DOI
-
Urinary microRNAs and Their Significance in Prostate Cancer Diagnosis: A 5-Year Update
CANCERS, year: 2022, volume: 14, edition: 13, DOI
2020
-
Cytoreductive Nephrectomy and Overall Survival of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy-Data from the National Renis Registry
Cancers, year: 2020, volume: 12, edition: 10, DOI
2019
-
Comparison of Different Treatment Modalities Outcomes in Clinically Node-positive Bladder Cancer: Analysis of a Population-based Cancer Registry
CLINICAL GENITOURINARY CANCER, year: 2019, volume: 17, edition: 4, DOI
-
Tyrosine kinase inhibitors in the first-line treatment for metastatic nonclear cell renal carcinoma: A retrospective analysis of a national database
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, year: 2019, volume: 37, edition: 4, DOI
2018
-
Clinically node-positive bladder cancer: oncological results of induction chemotherapy and consolidative surgery
Neoplasma, year: 2018, volume: 65, edition: 2, DOI
-
Genome-wide identification of urinary cell-free microRNAs for non-invasive detection of bladder cancer
Journal of Cellular and Molecular Medicine, year: 2018, volume: 22, edition: 3, DOI
-
Močové mikroRNA jako potenciální biomarkery karcinomu močového měchýře
Klinická Onkologie, year: 2018
2017
-
Detection of let-7 miRNAs in urine supernatant as potential diagnostic approach in non-metastatic clear-cell renal cell carcinoma
Biochemia Medica, year: 2017, volume: 27, edition: 2, DOI
-
Sada pro neinvazivní diagnostiku karcinomu močového měchýře na bázi močových mikroRNA
Year: 2017